This year may have started off on shaky footing as our nation tiptoed near the fiscal cliff, but when we look in the rear view mirror its undeniable that the bulls prevailed from the beginning through the finals trading days of 2013. While a number of asset classes posted dismal returns, namely precious metals and volatility, a number of others managed to post stellar gains, even topping the S&P 500′s impressive +28% return for the year [see The Worst Performing ETFs of 2013]. Improving growth prospects at home and signs of recovery overseas prompted many to scale back on defensive holdings and increase their risk appetites. As investors’ confidence grew so too did the demand for growth-sensitive securities. As such, ETFs focused on the cyclical alternative energy sector led the way higher trailed closely by those offering inverse exposure to volatility as well those targeting the biotech corner of the [...] Click here to read the original article on ETFdb.com. Related Posts: 7 ETF Types To Be Thankful For How To Invest In 2013′s Breakthrough Technologies Sector ETFs: Biggest Winners & Losers YTD Earth Day Special: Definitive Guide To Clean Energy ETFs ETF Picks For 3 Of The World’s Most Innovative Companies
This year may have started off on shaky footing as our nation tiptoed near the fiscal cliff, but when we look in the rear view mirror its undeniable that the bulls prevailed from the beginning through the finals trading days of 2013. While a number of asset classes posted dismal returns, namely precious metals and volatility, a number of others managed to post stellar gains, even topping the S&P 500′s impressive +28% return for the year [see The Worst Performing ETFs of 2013]. Improving growth prospects at home and signs of recovery overseas prompted many to scale back on defensive holdings and increase their risk appetites. As investors’ confidence grew so too did the demand for growth-sensitive securities. As such, ETFs focused on the cyclical alternative energy sector led the way higher trailed closely by those offering inverse exposure to volatility as well those targeting the biotech corner of the [...]
Click here to read the original article on ETFdb.com.
Related Posts:
